SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.
SPRC stock price ended at $1.01 on 목요일, after dropping 3.81%
On the latest trading day Jan 22, 2026, the stock price of SPRC fell by 3.81%, dropping from $0.98 to $1.01. During the session, the stock saw a volatility of 8.33%, with prices oscillating between a daily low of $0.96 and a high of $1.04. On the latest trading day, the trading volume for SPRC decreased by 2.7M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 332.5K shares were traded, with a market value of approximately $3.3M.
SPRC 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 0
매도 신호 5
Strong Sell
Sell
Neutral
Buy
Strong Buy
SPRC은 현재 2개의 매수 신호와 5개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -8.18%입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
SPRC에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 SPRC 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.